CHALKIS(SZ:000972)2025-01-23 13:55Financial Performance - The company expects a total profit loss of between 250 million to 150 million yuan for the year 2024, representing a decline of 328.59% compared to the previous year[3]. - The net profit attributable to shareholders is projected to be a loss of between 250 million to 150 million yuan, down 330.97% year-on-year[3]. - The operating revenue is estimated to be between 298 million to 350 million yuan, reflecting a decrease of 48.24% compared to the previous year[3]. - Non-recurring gains and losses are expected to impact net profit by approximately 77.4 million yuan, mainly from receivables impairment reversal and government subsidies[6]. - The company warns that its stock may face delisting risk due to negative financial indicators as per the Shenzhen Stock Exchange regulations[7]. - The financial data presented is preliminary and has not been audited by an accounting firm, with final figures to be disclosed in the 2024 annual report[7]. - The company emphasizes the importance of cautious investment decisions due to the significant projected losses[8]. Strategic Initiatives - The company plans to enhance its product structure by developing key products in the fast-moving consumer goods and health products sectors[6]. - The company is shifting its marketing strategy to focus more on domestic sales and is working to improve domestic market channels[6]. - The company has increased efforts to recover debts, which is part of its strategy to mitigate losses[6].